Familial hyperparathyroidism or hypocalciuric hypercalcaemia

Gene: RET

Green List (high evidence)

RET (ret proto-oncogene)
EnsemblGeneIds (GRCh38): ENSG00000165731
EnsemblGeneIds (GRCh37): ENSG00000165731
OMIM: 164761, Gene2Phenotype
RET is in 31 panels

2 reviews

Treena Cranston (Oxford)

Green List (high evidence)

Specific activating mutations - targeted analysis most appropriate
Created: 28 Jan 2019, 4:38 p.m.
Activating mutations in RET are causative of MEN2/MEN3. Hyperparathyroidism is a feature of MEN2A in approximately 30% of cases, it can also be the presenting feature (own data)
Created: 9 Jan 2019, 5:46 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
MEN2A, MEN3/MEN2B

Publications

Mode of pathogenicity
Other

Variants in this GENE are reported as part of current diagnostic practice

Ivone Leong (Genomics England Curator)

Submitted on behalf of Treena Cranston (Oxford): minimally cover exons 5,8,10,11,13,14,15 &16.
Created: 31 Jul 2019, 2:12 p.m. | Last Modified: 31 Jul 2019, 2:48 p.m.
Panel Version: 2.0
As discussed in the GMS Endocrinology Specialist Test Group webex call 28th Jan 2019: The Specialist Test Group agreed that there is enough evidence to rate this gene green.
Created: 29 Jan 2019, 11:52 a.m.
Comment on mode of pathogenicity: Variants in RET cause gain-of-function effects.
Created: 5 Dec 2018, 2:22 p.m.
RET is confirmed to be associated with Multiple endocrine neoplasia IIA and IIB on OMIM and Gene2Phenotype. RET is also a green gene in the Endocrine neoplasia panel (Version 1.7) and Thyroid cancer pertinent cancer susceptibility (Version 1.0). There are >3 cases of unrelated patients with multiple endocrine neoplasia IIA and IIB who have variants in RET on OMIM.
Created: 5 Dec 2018, 2:21 p.m.

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • Illumina TruGenome Clinical Sequencing Services
  • UKGTN
  • Emory Genetics Laboratory
Phenotypes
  • Multiple endocrine neoplasia IIB (162300)
  • Multiple endocrine neoplasia IIA (171400)/MEN3
OMIM
164761
Clinvar variants
Variants in RET
Penetrance
None
Publications
Mode of Pathogenicity
Other
Panels with this gene

History Filter Activity

30 Jan 2019, Gel status: 3

Panel promoted to version 1.0

Ivone Leong (Genomics England Curator)

Ivone Leong: RET is confirmed to be associa

29 Jan 2019, Gel status: 3

Set mode of inheritance

Ivone Leong (Genomics England Curator)

Mode of inheritance for gene: RET was changed from MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

10 Jan 2019, Gel status: 3

Set Phenotypes

Ivone Leong (Genomics England Curator)

Phenotypes for gene: RET were changed from Multiple endocrine neoplasia IIB (162300); Multiple endocrine neoplasia IIA (171400) to Multiple endocrine neoplasia IIB (162300); Multiple endocrine neoplasia IIA (171400)/MEN3

10 Jan 2019, Gel status: 3

Set publications

Ivone Leong (Genomics England Curator)

Publications for gene: RET were set to

8 Jan 2019, Gel status: 3

Entity classified by Genomics England curator

Ivone Leong (Genomics England Curator)

Gene: ret has been classified as Green List (High Evidence).

5 Dec 2018, Gel status: 3

Set mode of pathogenicity

Ivone Leong (Genomics England Curator)

Mode of pathogenicity for gene: RET was changed from to Other

5 Dec 2018, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Ivone Leong (Genomics England Curator)

gene: RET was added gene: RET was added to Familial hyperparathyroidism. Sources: Emory Genetics Laboratory,UKGTN,Illumina TruGenome Clinical Sequencing Services Mode of inheritance for gene: RET was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown Phenotypes for gene: RET were set to Multiple endocrine neoplasia IIB (162300); Multiple endocrine neoplasia IIA (171400)